Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-27T05:14:14.599Z Has data issue: false hasContentIssue false
  • English
  • Français

The Risk of Depression and Anxiety in the Post-diagnostic Period of Multiple Sclerosis Measured by Screening Instruments and Structured Interviews

Published online by Cambridge University Press:  23 March 2020

H. Hoang ,
E. Stenager  and
E. Stenager
H. Hoang
Affiliation:
Institute of Regional Health Service, Research Unit of Mental Health, University Hospital of Southern Denmark, Odense, Denmark
E. Stenager
Affiliation:
Institute of Regional Health Service, Research Unit of Mental Health, University Hospital of Southern Denmark, Odense, Denmark
E. Stenager
Affiliation:
Institute of Regional Health Service, Department of Neurology – Sønderborg, Odense, Denmark

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective

To examine the risk of depression and anxiety in MS patients in the post-diagnostic period by using clinical screening instruments and a diagnostic structured clinical interview.

Method

A population of 134 MS patients was examined for the risk of depression and anxiety in the post-diagnostic period of MS using the clinical screening instruments Beck Depression Inventory (BDI) and Hospital Anxiety and Depression Scale (HADS). Within six weeks of diagnosis, patients with cut-off > 12 for BDI and > 7 for HADS were offered a clinical structured interview using the Schedules for Clinical Assessment in Neuropsychiatry/SCAN Version 2.1.

Results

The prevalence of depressive symptoms and depression in the post-diagnostic period of MS was 49.2% when using the screening instruments, but only 15.2% when using the SCAN interview. For anxiety, the prevalence was 3.4% for both the screening instruments and the SCAN interview in the post-diagnostic period of MS.

Conclusion

MS patients have a risk of depression and anxiety in the post-diagnostic period of MS, but it is crucial to consider which tools to use in a clinical setting to investigate depression and anxiety in MS patients.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Keywords

Multiple sclerosisPsychiatric co-morbidityDepressionAnxietyHADSBDI-IIDiagnostic interview
Type
e-poster walk: Consultation liaison psychiatry and psychosomatics–Part 1
Information
European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S236
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.